Menu
PacPremier
Magic Hour
Montecito
Loading...
You are here:  Home  >  'Amgen'  -  Page 29
Latest

Amgen clinical trial shows promising results for migraine drug Aimovig

By   /  Tuesday, April 17th, 2018  /  Central Coast Health Watch, East Ventura County, Latest news, Technology  /  Comments Off on Amgen clinical trial shows promising results for migraine drug Aimovig

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen building plant in Rhode Island

By   /  Thursday, April 12th, 2018  /  Latest news, Technology  /  Comments Off on Amgen building plant in Rhode Island

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

European Union approves Amgen’s Xgeva to treat multiple myeloma

By   /  Tuesday, April 3rd, 2018  /  Central Coast Health Watch, Latest news, Technology, Tri-County Public Companies  /  Comments Off on European Union approves Amgen’s Xgeva to treat multiple myeloma

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets FDA approval for Blincyto

By   /  Thursday, March 29th, 2018  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen gets FDA approval for Blincyto

Shares for Amgen ticked up 50 cents after the company announced March 29 that its cancer drug Blincyto had received U.S. Food and Drug Administration approval to treat patients in their first or second remission. The decision makes Blincyto the first therapy to be approved to treat patients with minimal residual disease, or MRD, the Read More →

Read More →
Latest

European regulators have good news for Amgen

By   /  Friday, March 23rd, 2018  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on European regulators have good news for Amgen

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen spends $10 billion to buy back 52.1 million shares

By   /  Tuesday, March 6th, 2018  /  Central Coast Health Watch, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen spends $10 billion to buy back 52.1 million shares

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Night Lizard Brewing Co. combines conservation with beer

By   /  Friday, March 2nd, 2018  /  Latest news, Small Business  /  Comments Off on Night Lizard Brewing Co. combines conservation with beer

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →